Le Lézard
Classified in: Health, Business
Subjects: DIV, ACC

DSM Announces Repurchase of Shares to Cover Share-based Compensation Plans and Stock Dividend


HEERLEN, Netherlands, August 13, 2018 /PRNewswire/ --

Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, today announces that, starting 13 August 2018, it intends to repurchase in total 1,100,000 ordinary shares: 500,000 ordinary shares to cover commitments under share-based compensation plans and 600,000 ordinary shares to cover commitments for stock dividend as part of the interim dividend 2018. Based on the closing price of the DSM share on Euronext Amsterdam on 10 August 2018 this would be equivalent to approximately ?99 million. 

     (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )

DSM has signed a Discretionary Management Agreement with the bank that will execute the repurchase. The repurchase price will be based on the daily VWAP (Volume Weighted Average Price). Volumes to be repurchased will be on average 5% of the daily trading volume on the open market, within a bandwidth of 2-8% per day. The total share repurchase program is anticipated to continue into Q4 2018. The total number of shares to be repurchased under this program represents approximately 0.6% of ordinary shares issued.

In accordance with financial market regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases.

DSM - Bright Science. Brighter Living.tm 

Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about ?10 billion with approximately 23,000 employees. The company is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com.

Or find us on:

Facebook

Twitter

LinkedIn

YouTube

For more information:

DSM Media Relations
Lieke de Jong
tel. +31(0)45-578-2420
e-mail [email protected]

DSM Investor Relations
Dave Huizing
tel. +31(0)45-5782864
e-mail [email protected]


These press releases may also interest you

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...

at 17:00
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....

at 16:55
Veterinary Management Groups (VMG) is proud to...

at 16:45
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered...



News published on and distributed by: